Investigational Drug Information for Adavosertib
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
What is the development status for investigational drug Adavosertib?
Adavosertib is an investigational drug.
There have been 29 clinical trials for Adavosertib. The most recent clinical trial was a Phase 1 trial, which was initiated on July 21st 2014.
The most common disease conditions in clinical trials are Neoplasms, Carcinoma, and Adenocarcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), AstraZeneca, and Parexel.
There are twenty-seven US patents protecting this investigational drug and three hundred and forty-seven international patents.
Summary for Adavosertib
|US Patent Applications||232|
|WIPO Patent Applications||223|
|Japanese Patent Applications||44|
|Clinical Trial Progress||Phase 1 (2014-07-21)|
Recent Clinical Trials for Adavosertib
|Adavosertib and Gemcitabine in Advanced Pancreatic||AstraZeneca||Phase 2|
|Adavosertib and Gemcitabine in Advanced Pancreatic||Lustgarten Foundation||Phase 2|
|Adavosertib and Gemcitabine in Advanced Pancreatic||Stand Up To Cancer||Phase 2|
Clinical Trial Summary for Adavosertib
Top disease conditions for Adavosertib
Top clinical trial sponsors for Adavosertib
US Patents for Adavosertib
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Adavosertib||⤷ Try a Trial||Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids||Cantex Pharmaceuticals, Inc. (Weston, FL)||⤷ Try a Trial|
|Adavosertib||⤷ Try a Trial||Silanol based therapeutic payloads||BlinkBio, Inc. (Jupiter, FL)||⤷ Try a Trial|
|Adavosertib||⤷ Try a Trial||Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer||AstraZeneca AB (Sodertalje, SE)||⤷ Try a Trial|
|Adavosertib||⤷ Try a Trial||Methods and compositions for treatment of cancer and autoimmune disease||THE JACKSON LABORATORY (Bar Harbor, ME)||⤷ Try a Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
International Patents for Adavosertib
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Adavosertib||European Patent Office||EP3258941||2035-02-17||⤷ Try a Trial|
|Adavosertib||World Intellectual Property Organization (WIPO)||WO2016133910||2035-02-17||⤷ Try a Trial|
|Adavosertib||Australia||AU2017277949||2036-06-09||⤷ Try a Trial|
|Adavosertib||Canada||CA3026651||2036-06-09||⤷ Try a Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|